Hyderabad, May 16: The price of Covid-19 vaccine Corbevax has been reduced to Rs 250 a dose from its earlier Rs 840, said Biological E Limited (BE) on Monday.
For end-user, the price would be Rs 400 a dose, including taxes and administration charges, added the pharmaceutical company. Earlier in April, the Drugs Controller General of India (DCGI) granted emergency use authorisation to Biological E's Covid-19 vaccine Corbevax for those aged 5 to 12 years, informed the pharmaceutical company.
Corbevax is currently being administered to children in the age group of 12-14.
Biological E Limited has manufactured 30 crore doses of Corbevax and has already supplied nearly 10 crore doses to the Central Government.
Also Read | No heatwave for next four days in Delhi: IMD
Currently, over 3 crore doses of Corbevax have been administered to children between 12-15 years of age. Covid-19 vaccination for minors in India started from January 3 onwards for those in the 15-18 age group with Bharat Biotech's Covaxin.
The drive later expanded on March 16 to include children aged above 12 for Corbevax. India is currently administering two Covid-19 vaccines for children above 12.
Meanwhile, India continued to witness a dip in the new Covid cases, as the country reported 2,202 fresh infections in the last 24 hours, according to the Union Ministry of Health and Family Welfare on Monday.
The daily positivity rate of the country witnessed a minor rise from 0.61 per cent on Sunday to 0.74 per cent on Monday, while the weekly positivity rate declined from 0.62 per cent yesterday to 0.59 per cent on Monday. With this, the active cases in the country stand at 17,317 which accounts for 0.04 per cent of the total cases.
As many as 2,550 Covid patients recovered from the disease in the last 24 hours taking the total number of recoveries to 4,25,82,243. The recovery rate currently is 98.74 per cent.